Clinical Trial Update: Testing Obeticholic Acid for Familial Adenomatous Polyposis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of obeticholic acid for attenuated familial adenomatous polyposis is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Carcinoma
• Duodenal Carcinoma
• Familial Adenomatous Polyposis

Drugs mentioned

• Obeticholic acid (obeticholic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma | Phase 2 | Status: SUSPENDED